Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey

Gregory Y H Lip; Maria Grazia Bongiorni; Dan Dobreanu; Thorsten Lewalter; Jesper Hastrup Svendsen; Carina Blomström-Lundqvist; Scientific Initiative Committee, European Heart Rhythm Association

doi:10.1093/europace/eut292

Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey

Gregory Y H Lip, Maria Grazia Bongiorni, Dan Dobreanu, Thorsten Lewalter, Jesper Hastrup Svendsen, Carina Blomström-Lundqvist, Scientific Initiative Committee, European Heart Rhythm Association

21 Citations (Scopus)

Abstract

The purpose of this European Heart Rhythm Association (EHRA) survey was to assess clinical practice in relation to stroke prevention in atrial fibrillation (AF), particularly into the use of novel oral anticoagulants (NOACs) for stroke prevention, among members of the EHRA electrophysiology (EP) research network. In this EP Wire survey, we have provided some insights into current practice in Europe for the use of NOACs for stroke prevention in AF. There were clear practice differences evident, and also the need for greater adherence to the guidelines, especially since guideline adherent management results in better outcomes in AF.

Original language	English
Journal	Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Volume	15
Issue number	10
Pages (from-to)	1526-32
Number of pages	7
ISSN	1099-5129
DOIs	https://doi.org/10.1093/europace/eut292
Publication status	Published - Oct 2013

Keywords

Administration, Oral
Anticoagulants
Atrial Fibrillation
Blood Coagulation
Blood Coagulation Tests
Drug Monitoring
Drug Utilization Review
Europe
Guideline Adherence
Health Care Surveys
Hemorrhage
Humans
Practice Guidelines as Topic
Practice Patterns, Physicians'
Risk Factors
Stroke
Surveys and Questionnaires
Time Factors
Treatment Outcome
Journal Article

Access to Document

10.1093/europace/eut292

Cite this

Lip, G. Y. H., Bongiorni, M. G., Dobreanu, D., Lewalter, T., Hastrup Svendsen, J., Blomström-Lundqvist, C., & Scientific Initiative Committee, European Heart Rhythm Association (2013). Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(10), 1526-32. https://doi.org/10.1093/europace/eut292

Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey. / Lip, Gregory Y H; Bongiorni, Maria Grazia; Dobreanu, Dan et al.
In: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 15, No. 10, 10.2013, p. 1526-32.

Research output: Contribution to journal › Journal article › Research › peer-review

Lip, GYH, Bongiorni, MG, Dobreanu, D, Lewalter, T, Hastrup Svendsen, J, Blomström-Lundqvist, C & Scientific Initiative Committee, European Heart Rhythm Association 2013, 'Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey', Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, vol. 15, no. 10, pp. 1526-32. https://doi.org/10.1093/europace/eut292

Lip GYH, Bongiorni MG, Dobreanu D, Lewalter T, Hastrup Svendsen J, Blomström-Lundqvist C et al. Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2013 Oct;15(10):1526-32. doi: 10.1093/europace/eut292

Lip, Gregory Y H ; Bongiorni, Maria Grazia ; Dobreanu, Dan et al. / Novel oral anticoagulants for stroke prevention in atrial fibrillation : results of the European Heart Rhythm Association survey. In: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2013 ; Vol. 15, No. 10. pp. 1526-32.

@article{85291b302ebe4b5fbc1c195baeb75466,

title = "Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey",

abstract = "The purpose of this European Heart Rhythm Association (EHRA) survey was to assess clinical practice in relation to stroke prevention in atrial fibrillation (AF), particularly into the use of novel oral anticoagulants (NOACs) for stroke prevention, among members of the EHRA electrophysiology (EP) research network. In this EP Wire survey, we have provided some insights into current practice in Europe for the use of NOACs for stroke prevention in AF. There were clear practice differences evident, and also the need for greater adherence to the guidelines, especially since guideline adherent management results in better outcomes in AF.",

keywords = "Administration, Oral, Anticoagulants, Atrial Fibrillation, Blood Coagulation, Blood Coagulation Tests, Drug Monitoring, Drug Utilization Review, Europe, Guideline Adherence, Health Care Surveys, Hemorrhage, Humans, Practice Guidelines as Topic, Practice Patterns, Physicians', Risk Factors, Stroke, Surveys and Questionnaires, Time Factors, Treatment Outcome, Journal Article",

author = "Lip, \{Gregory Y H\} and Bongiorni, \{Maria Grazia\} and Dan Dobreanu and Thorsten Lewalter and \{Hastrup Svendsen\}, Jesper and Carina Blomstr{\"o}m-Lundqvist and \{Scientific Initiative Committee, European Heart Rhythm Association\}",

year = "2013",

month = oct,

doi = "10.1093/europace/eut292",

language = "English",

volume = "15",

pages = "1526--32",

journal = "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology",

issn = "1099-5129",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - Novel oral anticoagulants for stroke prevention in atrial fibrillation

T2 - results of the European Heart Rhythm Association survey

AU - Lip, Gregory Y H

AU - Bongiorni, Maria Grazia

AU - Dobreanu, Dan

AU - Lewalter, Thorsten

AU - Hastrup Svendsen, Jesper

AU - Blomström-Lundqvist, Carina

AU - Scientific Initiative Committee, European Heart Rhythm Association

PY - 2013/10

Y1 - 2013/10

N2 - The purpose of this European Heart Rhythm Association (EHRA) survey was to assess clinical practice in relation to stroke prevention in atrial fibrillation (AF), particularly into the use of novel oral anticoagulants (NOACs) for stroke prevention, among members of the EHRA electrophysiology (EP) research network. In this EP Wire survey, we have provided some insights into current practice in Europe for the use of NOACs for stroke prevention in AF. There were clear practice differences evident, and also the need for greater adherence to the guidelines, especially since guideline adherent management results in better outcomes in AF.

AB - The purpose of this European Heart Rhythm Association (EHRA) survey was to assess clinical practice in relation to stroke prevention in atrial fibrillation (AF), particularly into the use of novel oral anticoagulants (NOACs) for stroke prevention, among members of the EHRA electrophysiology (EP) research network. In this EP Wire survey, we have provided some insights into current practice in Europe for the use of NOACs for stroke prevention in AF. There were clear practice differences evident, and also the need for greater adherence to the guidelines, especially since guideline adherent management results in better outcomes in AF.

KW - Administration, Oral

KW - Anticoagulants

KW - Atrial Fibrillation

KW - Blood Coagulation

KW - Blood Coagulation Tests

KW - Drug Monitoring

KW - Drug Utilization Review

KW - Europe

KW - Guideline Adherence

KW - Health Care Surveys

KW - Hemorrhage

KW - Humans

KW - Practice Guidelines as Topic

KW - Practice Patterns, Physicians'

KW - Risk Factors

KW - Stroke

KW - Surveys and Questionnaires

KW - Time Factors

KW - Treatment Outcome

KW - Journal Article

UR - https://www.scopus.com/pages/publications/84885002061

U2 - 10.1093/europace/eut292

DO - 10.1093/europace/eut292

M3 - Journal article

C2 - 24072770

SN - 1099-5129

VL - 15

SP - 1526

EP - 1532

JO - Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

JF - Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

IS - 10

ER -

Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this